Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Leukemia, Lymphoid × blinatumomab × Clear all

Phase

Status

Completed 2 Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Burkitt Lymphoma 3 Neoplasm, Residual 2 Leukemia 2 Myasthenia Gravis 1 Leukemia, Lymphoid 1 Graft vs Host Disease 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06075238 2023-10-10

Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT

Sichuan University

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Lymphoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡